Systemic Allergic Reactions to SARS-CoV-2 vaccination
Showing 1 - 25 of >10,000
SARS-CoV Infection, COVID-19, Allergic Reaction Trial in United States (Moderna COVID-19 Vaccine, Pfizer-BioNTech COVID-19
Completed
- SARS-CoV Infection
- +3 more
- Moderna COVID-19 Vaccine
- +2 more
-
Tucson, Arizona
- +28 more
Sep 19, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in
Not yet recruiting
- Systemic Sclerosis
- SARS-CoV 2 Vaccination
- (no location specified)
Jul 24, 2023
Systemic Lupus Trial in Strasbourg (SRAS-CoV-2 vaccination immunological response)
Recruiting
- Systemic Lupus
- SRAS-CoV-2 vaccination immunological response
-
Strasbourg, Bas-Rhin, FranceUniversity Hospital of Hautepierre
Aug 17, 2022
Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2
Recruiting
- Influenza
- COVID-19
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 13, 2022
SARS-CoV-2 Vaccination on Cancer Patients Infected With
Recruiting
- COVID-19 Infection
- COVID-19 Vaccine
- no intervention
-
Beijing, Beijing, ChinaSanhuan Cancer Hospital, Chaoyang District, Beijing(Cancer Hospi
Mar 7, 2023
COVID-19 Vaccine, COVID-19 Trial in Bangkok (50 µg Baiya SARS-CoV-2 Vax 2, Placebo)
Not yet recruiting
- COVID-19 Vaccine
- COVID-19
- 50 μg Baiya SARS-CoV-2 Vax 2
- Placebo
-
Bangkok, ThailandQueen Saovabha Memorial Institute
May 23, 2023
SARS-CoV-2 Trial in Islamabad (SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021), 0.9% sodium chloride solution)
Recruiting
- SARS-CoV-2
- SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021)
- 0.9% sodium chloride solution
-
Islamabad, PakistanSindh Infectious Diseases Hospital & Research Center Dow Univers
Apr 16, 2023
COVID-19 Transmission and Morbidity in Malawi
Recruiting
- SARS CoV 2 Infection
- SARS CoV 2 Vaccination
-
Boston, Massachusetts
- +1 more
Aug 6, 2023
Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in
Active, not recruiting
- SARS-CoV-2 RNA Vaccines
- HIV Infection
- SARS-CoV-2 Vaccine
-
Sevilla, SpainVirgen del Rocio University Hospital
Dec 1, 2022
SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Recombinant SARS-CoV-2 vaccine, Saline)
Not yet recruiting
- SARS-CoV-2
- SARS-CoV-2 Bivalent mRNA Vaccine
- +2 more
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023
SARS-CoV-2 Vaccine Tolerability and Clinical Outcome Among
Completed
- SARS-CoV2 Infection
- +3 more
- IM injection of vaccination (mRNA vaccination)
- IM injection of vaccination (vector based vaccination)
-
Hildesheim, Niedersachsen, GermanyHelios Hospital Hildesheim
Dec 29, 2022
COVID-19 Trial in Guangzhou (the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine)
Recruiting
- COVID-19
- the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine
-
Guangzhou, Guangzhou, ChinaThe Fifth Affiliated Hospital of Guangzhou Medical University
Jan 28, 2023
Vaccination Hesitancy Trial in Oklahoma City, Stillwater (Standard MI, Intensive MI, MOTIVACC)
Not yet recruiting
- Vaccination Hesitancy
- Standard MI
- +3 more
-
Oklahoma City, Oklahoma
- +1 more
Aug 2, 2023
SARS Cov 2 Vaccination in Juvenile Idiopathic Arthritis
Recruiting
- SARS Cov 2 Vaccination in Adolescents With Juvenile Idiopathic Arthritis
-
Nantes, Loire-Atlantique, FranceCHU de Nantes
Sep 16, 2022
Survey of Symptoms After a COVID Vaccination in Employees
Completed
- Symptoms Recoding SARS-CoV-2 After Vaccination
- questionnaire
-
Graz, Styria, AustriaMedical University of Graz
Sep 6, 2023
Sars-cov-2 on Donor Oocyte Quality and Quantity,Multicenter
Completed
- Ovarian Reserve
- +2 more
- Sars Cov 2 infection
- Sars Cov 2 vaccination
-
Bogotá, ColombiaNovafem
Oct 3, 2022
Security Efficacy COVID-19 Vaccination
Completed
- Autoimmune State
- SARS-CoV-2 Infection
- Blood sampling
-
Milan, ItalyIstituto Auxologico Italiano IRCCS
Feb 23, 2023
After SARS CoV2 Vaccination in Kidney Transplant Recipients
Recruiting
- Kidney Transplant Recipients
- Study of the synthesis of antibodies directed against SARS
-
Strasbourg, FranceCaillard Sophie
Aug 18, 2022
Japan of Shock and Anaphylaxis After Severe Acute Respiratory
Active, not recruiting
- SARS-CoV-2
-
Tokyo, JapanCMIC Co., Ltd.
Jun 5, 2023
Coronavirus Trial in Oxford (SARS-CoV-2 virus)
Recruiting
- Coronavirus
- SARS-CoV-2 virus
-
Oxford, Oxon, United Kingdom
- +2 more
Jan 5, 2023
Effect of SARS-CoV-2 Vaccination in Liver Transplant Recipients
Completed
- SARS-CoV-2 Vaccination
- Liver Transplantation
- Immunoassay, by ECLIA, for the quantitative in vitro determination of antibodies (including IgG) to the SARS - CoV - 2 spike protein (S) anti-RBD (receptor-binding domain) in serum and plasma samples.
-
Roma, ItalyPoliclinico Tor Vergata
Aug 3, 2022
Cancer Trial in Anderlecht (Spikevax, Comirnaty)
Recruiting
- Cancer
- Spikevax
- Comirnaty
-
Anderlecht, Belgium
- +1 more
Aug 30, 2022
Covid19 Trial in Cypress (VXA-CoV2-1)
Completed
- Covid19
- VXA-CoV2-1
-
Cypress, CaliforniaWCCT
Jan 17, 2023
HIV Seropositivity, Immunodeficiency, Vaccination Reaction Trial in Ghent (Blood draw)
Recruiting
- HIV Seropositivity
- +3 more
- Blood draw
-
Ghent, East Flanders, BelgiumUH Ghent
Jan 4, 2023
SARS-CoV Infection Trial in Brussels (serological testing)
Active, not recruiting
- SARS-CoV Infection
- serological testing
-
Brussels, BelgiumUniversitair ziekenhuis Brussel
May 17, 2022